| Literature DB >> 22732221 |
Sun Hwa Lee1, Dae Won Kim, Seon Ae Eom, Se-Young Jun, Meeyoung Park, Duk-Soo Kim, Hyung Joo Kwon, Hyeok Yil Kwon, Kyu Hyung Han, Jinseu Park, Hyun Sook Hwang, Won Sik Eum, Soo Young Choi.
Abstract
We examined that the protective effects of ANX1 on 12-O-tetradecanoylphorbol- 13-acetate (TPA)-induced skin inflammation in animal models using a Tat-ANX1 protein. Topical application of the Tat-ANX1 protein markedly inhibited TPAinduced ear edema and expression levels of cyclooxygenase-2 (COX-2) as well as pro-inflammatory cytokines such as interleukin- 1 beta (IL-1 β), IL-6, and tumor necrosis factor-alpha (TNF-α). Also, application of Tat-ANX1 protein significantly inhibited nuclear translocation of nuclear factor-kappa B (NF-κ B) and phosphorylation of p38 and extracellular signalregulated kinase (ERK) mitogen-activated protein kinase (MAPK) in TPA-treated mice ears. The results indicate that Tat-ANX1 protein inhibits the inflammatory response by blocking NF-κ B and MAPK activation in TPA-induced mice ears. Therefore, the Tat-ANX1 protein may be useful as a therapeutic agent against inflammatory skin diseases.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22732221 DOI: 10.5483/bmbrep.2012.45.6.036
Source DB: PubMed Journal: BMB Rep ISSN: 1976-6696 Impact factor: 4.778